We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current HOWL market cap is 264.97M. The company's latest EPS is USD -0.8744 and P/E is -7.71.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.97M | 7.28M | 4.46M | 8.08M | 5.9M |
| Operating Income | -12.54M | -13.18M | -12.22M | -6.07M | -9.25M |
| Net Income | -11.94M | -11.93M | -11.98M | -5.1M | -8.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 16.4M | 19.94M |
| Operating Income | -9.94M | -22.4M | -50.09M | -56.06M | -40.5M |
| Net Income | -18.23M | -28.22M | -201.93M | -53.81M | -37.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 172.42M | 160.25M | 195.07M | 185.24M | 176.39M |
| Total Liabilities | 41.48M | 37.91M | 74M | 66.64M | 63.94M |
| Total Equity | 130.95M | 122.34M | 121.07M | 118.6M | 112.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 21.68M | 96.4M | 179.25M | 160.25M | 174.83M |
| Total Liabilities | 11.91M | 7.18M | 26.46M | 37.91M | 63.46M |
| Total Equity | -24.3M | -51.86M | 152.79M | 122.34M | 111.37M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28.73M | -40.6M | -9.9M | -20.82M | -28.03M |
| Investing | -3.09M | -3.61M | -168k | -350k | -571k |
| Financing | 14.65M | 15.91M | 48.62M | 49.32M | 49.36M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -9.54M | -18.62M | -42.88M | -40.6M | -32.61M |
| Investing | -266k | -560k | -498k | -3.61M | -769k |
| Financing | 21.91M | 93.86M | 109.43M | 15.91M | 58.43M |
| Market Cap | 264.97M |
| Price to Earnings Ratio | -7.71 |
| Price to Sales Ratio | 14.44 |
| Price to Cash Ratio | 2.14 |
| Price to Book Ratio | 2.59 |
| Dividend Yield | - |
| Shares Outstanding | 42.74M |
| Average Volume (1 week) | 183.33k |
| Average Volume (1 Month) | 195.44k |
| 52 Week Change | 162.71% |
| 52 Week High | 8.1939 |
| 52 Week Low | 1.5735 |
| Spread (Intraday) | 0.75 (10.71%) |
| Company Name | Werewolf Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://werewolftx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
